Rockwell Medical (RMTI) Gross Profit (2010 - 2026)

Rockwell Medical has reported Gross Profit for 17 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 4.77% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.5 million (down 33.86% YoY), and the FY2025 full-year result was $11.7 million, down 33.11% from the prior year.
• Gross Profit for Q1 2026 stood at $2.9 million, down from $3.9 million in the prior quarter.
• The five-year high for Gross Profit was $6.2 million in Q3 2024, with the low at -$786000.0 in Q1 2022.
• Historically, Gross Profit has averaged $2.6 million across 5 years, with a median of $2.6 million in 2023.
• The largest YoY upside for Gross Profit was 766.03% in 2022 against a maximum downside of 296.01% in 2022.
• Rockwell Medical's Gross Profit stood at $2.3 million in 2022, then advanced by 22.65% to $2.9 million in 2023, then climbed by 26.52% to $3.6 million in 2024, then gained by 6.8% to $3.9 million in 2025, then decreased by 25.3% to $2.9 million in 2026.
• The last three Gross Profit figures came in at $2.9 million (Q1 2026), $3.9 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.